Breakthrough epilepsy monitoring device receives investment funding

Seer Medical’s Mark Cook, in conjunction with The Bionics Institute, St Vincent’s Melbourne and the University of Melbourne has launched a new Australian venture to develop a breakthrough monitoring device to improve management of epilepsy and seizure-related conditions – Minder ™.

The successful venture with an initial A$3.65 million investment from Cochlear Ltd and other Australian investors is a culmination of a decade of research and development into improving outcomes for Epilepsy sufferers and has been led by Seer Director, Prof Mark Cook and A/Prof Chris Williams from the Bionics Institute.

Read more about the device on the Bionics Institute website here.